The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD)
Open accessAbstract
SummaryThe present guideline (S2k) on allergen-specific immunotherapy (AIT) was established by the German, Austrian and Swiss professional associations for allergy in consensus with the scientific specialist societies and professional associations in the fields of otolaryngology, dermatology and venereology, pediatric and adolescent medicine, pneumology as well as a German patient organization (German Allergy and Asthma Association; Deutscher Allergie- und Asthmabund, DAAB) according to the criteria of the Association of the Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF).AIT is a therapy with disease-modifying effects. By administering allergen extracts, specific blocking antibodies, toler-ance-inducing cells and mediators are activated. These prevent further exacerbation of the allergen-triggered immune response, block the specific immune response and attenuate the inflammatory response in tissue.Products for SCIT or SLIT cannot be compared at present due to their heterogeneous composition, nor can allergen concentrations given by different manufacturers be compared meaningfully due to the varying methods used to measure their active ingredients. Non-modified allergens are used for SCIT in the form of aqueous or physically adsorbed (depot) extracts, as well as chemically modified allergens (allergoids) as depot extracts. Allergen extracts for SLIT are used in the form of aqueous solutions or tablets.The clinical efficacy of AIT is measured using various scores as primary and secondary study endpoints. The EMA stipulates combined symptom and medication scores as primary endpoint. A harmonization of clinical endpoints, e. g., by using the combined symptom and medication scores (CSMS) recommended by the EAACI, is desirable in the future in order to permit the comparison of results from different studies. The current CONSORT recommendations from the ARIA/GA2LEN group specify standards for the evaluation, presentation and publication of study results.According to the Therapy allergen ordinance (TAV), preparations containing common allergen sources (pollen from grasses, birch, alder, hazel, house dust mites, as well as bee and wasp venom) need a marketing authorization in Germany. During the marketing authorization process, these preparations are examined regarding quality, safety and efficacy. In the opinion of the authors, authorized allergen preparations with documented efficacy and safety, or preparations tradeable under the TAV for which efficacy and safety have already been documented in clinical trials meeting WAO or EMA standards, should be preferentially used. Individual formulations (NPP) enable the prescription of rare allergen sources (e.g., pollen from ash, mugwort or ambrosia, mold Alternaria, animal allergens) for specific immunotherapy. Mixing these allergens with TAV allergens is not permitted.Allergic rhinitis and its associated co-morbidities (e. g., bronchial asthma) generate substantial direct and indirect costs. Treatment options, in particular AIT, are therefore evaluated using cost-benefit and cost-effectiveness analyses. From a long-term perspective, AIT is considered to be significantly more cost effective in allergic rhinitis and allergic asthma than pharmacotherapy, but is heavily dependent on patient compliance.Meta-analyses provide unequivocal evidence of the efficacy of SCIT and SLIT for certain allergen sources and age groups. Data from controlled studies differ in terms of scope, quality and dosing regimens and require product-specific evaluation. Therefore, evaluating individual preparations according to clearly defined criteria is recommended. A broad transfer of the efficacy of certain preparations to all preparations administered in the same way is not endorsed. The website of the German Society for Allergology and Clinical Immunology (www.dgaki.de/leitlinien/s2k-leitlinie-sit; DGAKI: Deutsche Gesellschaft für Allergologie und klinische Immunologie) provides tables with specific information on available products for AIT in Germany, Switzerland and Austria. The tables contain the number of clinical studies per product in adults and children, the year of market authorization, underlying scoring systems, number of randomized and analyzed subjects and the method of evaluation (ITT, FAS, PP), separately given for grass pollen, birch pollen and house dust mite allergens, and the status of approval for the conduct of clinical studies with these products.Strong evidence of the efficacy of SCIT in pollen allergy-induced allergic rhinoconjunctivitis in adulthood is well-documented in numerous trials and, in childhood and adolescence, in a few trials. Efficacy in house dust mite allergy is documented by a number of controlled trials in adults and few controlled trials in children. Only a few controlled trials, independent of age, are available for mold allergy (in particular Alternaria). With regard to animal dander allergies (primarily to cat allergens), only small studies, some with methodological deficiencies are available. Only a moderate and inconsistent therapeutic effect in atopic dermatitis has been observed in the quite heterogeneous studies conducted to date. SCIT has been well investigated for individual preparations in controlled bronchial asthma as defined by the Global Initiative for Asthma (GINA) 2007 and intermittent and mild persistent asthma (GINA 2005) and it is recommended as a treatment option, in addition to allergen avoidance and pharmacotherapy, provided there is a clear causal link between respiratory symptoms and the relevant allergen.The efficacy of SLIT in grass pollen-induced allergic rhinoconjunctivitis is extensively documented in adults and children, whilst its efficacy in tree pollen allergy has only been shown in adults. New controlled trials (some with high patient numbers) on house dust mite allergy provide evidence of efficacy of SLIT in adults.Compared with allergic rhinoconjunctivitis, there are only few studies on the efficacy of SLIT in allergic asthma. In this context, newer studies show an efficacy for SLIT on asthma symptoms in the subgroup of grass pollen allergic children, adolescents and adults with asthma and efficacy in primary house dust mite allergy-induced asthma in adolescents aged from 14 years and in adults.Aspects of secondary prevention, in particular the reduction of new sensitizations and reduced asthma risk, are important rationales for choosing to initiate treatment early in childhood and adolescence. In this context, those products for which the appropriate effects have been demonstrated should be considered.SCIT or SLIT with pollen or mite allergens can be performed in patients with allergic rhinoconjunctivitis using allergen extracts that have been proven to be effective in at least one double-blind placebo-controlled (DBPC) study. At present, clinical trials are underway for the indication in asthma due to house dust mite allergy, some of the results of which have already been published, whilst others are still awaited (see the DGAKI table “Approved/potentially completed studies” via www.dgaki.de/Leitlinien/s2k-Leitlinie-sit (according to www.clinicaltrialsregister.eu)). When establishing the indication for AIT, factors that favour clinical efficacy should be taken into consideration. Differences between SCIT and SLIT are to be considered primarily in terms of contraindications. In individual cases, AIT may be justifiably indicated despite the presence of contraindications.SCIT injections and the initiation of SLIT are performed by a physician experienced in this type of treatment and who is able to administer emergency treatment in the case of an allergic reaction. Patients must be fully informed about the procedure and risks of possible adverse events, and the details of this process must be documented (see “Treatment information sheet”; available as a handout via www.dgaki.de/Leitlinien/s2k-Leitlinie-sit). Treatment should be performed according to the manufacturer‘s product information leaflet. In cases where AIT is to be performed or continued by a different physician to the one who established the indication, close cooperation is required in order to ensure that treatment is implemented consistently and at low risk. In general, it is recommended that SCIT and SLIT should only be performed using preparations for which adequate proof of efficacy is available from clinical trials.Treatment adherence among AIT patients is lower than assumed by physicians, irrespective of the form of administration. Clearly, adherence is of vital importance for treatment success. Improving AIT adherence is one of the most important future goals, in order to ensure efficacy of the therapy.Severe, potentially life-threatening systemic reactions during SCIT are possible, but – providing all safety measures are adhered to – these events are very rare. Most adverse events are mild to moderate and can be treated well.Dose-dependent adverse local reactions occur frequently in the mouth and throat in SLIT. Systemic reactions have been described in SLIT, but are seen far less often than with SCIT. In terms of anaphylaxis and other severe systemic reactions, SLIT has a better safety profile than SCIT.The risk and effects of adverse systemic reactions in the setting of AIT can be effectively reduced by training of personnel, adhering to safety standards and prompt use of emergency measures, including early administration of i. m. epinephrine. Details on the acute management of anaphylactic reactions can be found in the current S2 guideline on anaphylaxis issued by the AWMF (S2-AWMF-LL Registry Number 061-025).AIT is undergoing some innovative developments in many areas (e. g., allergen characterization, new administration routes, adjuvants, faster and safer dose escalation protocols), some of which are already being investigated in clinical trials.Cite this as Pfaar O, Bacher
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
Self-citationKirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
PROPHYLACTIC INOCULATION AGAINST HAY FEVER
Noon, L. (1911) · The Lancet · doi:10.1016/s0140-6736(00)78276-6 · Cited by 1,351
Möller, C., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Jacobsen, L., Koivikko, A., Koller, D. Y., Niggemann, B., Norberg, L. A., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121317 · Cited by 1,065
Akdis, M., Verhagen, J., Taylor, A., Karamloo, F., Karagiannidis, C., Crameri, R., Thunberg, S., Deniz, G., Valenta, R., Fiebig, H., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032058 · Cited by 1,052
Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Koivikko, A., Norberg, L. A., Valovirta, E., Wahn, U., et al. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01451.x · Cited by 976
Mechanisms of allergen-specific immunotherapy
Akdis, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 803
Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
Bousquet, J., Lockey, R., Malling, H. J., Alvarez-Cuesta, E., Canonica, G. W., Chapman, M. D., Creticos, P. J., Dayer, J. M., Durham, S. R., Demoly, P., et al. (1998) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63136-5 · Cited by 736
Allergic Rhinitis and its Impact on Asthma (ARIA)
Bousquet, J. (2003) · Clinical & Experimental Allergy Reviews · doi:10.1046/j.1472-9725.2003.00063.x · Cited by 734
Allergen injection immunotherapy for seasonal allergic rhinitis
Calderon, M. A., Alves, B., Jacobson, M., Hurwitz, B., Sheikh, A., & Durham, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001936.pub2 · Cited by 678 · cited 1×
“, grass pollen, birch pollen) in a systematic review and meta-analysis in 2007 [48].”
BackgroundAllergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
Bousquet, J., Schünemann, H. J., Samolinski, B., Demoly, P., Baena-Cagnani, C. E., Bachert, C., Bonini, S., Boulet, L. P., Bousquet, P. J., Brozek, J. L., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.053 · Cited by 623
Self-citationRhinitis and onset of asthma: a longitudinal population-based study
Shaaban, R., Zureik, M., Soussan, D., Neukirch, C., Heinrich, J., Sunyer, J., Wjst, M., Cerveri, I., Pin, I., Bousquet, J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61446-4 · Cited by 610 · cited 1×
“5-fold higher relative risk of developing bronchial asthma within less than 10 years [33].”
BackgroundSublingual immunotherapy: World Allergy Organization position paper 2013 update
Canonica, G. W., Cox, L., Pawankar, R., Baena-Cagnani, C. E., Blaiss, M., Bonini, S., Bousquet, J., Calderón, M., Compalati, E., Durham, S. R., et al. (2014) · World Allergy Organization Journal · doi:10.1186/1939-4551-7-6 · Cited by 591
Self-citationGrass Pollen Immunotherapy Induces Mucosal and Peripheral IL-10 Responses and Blocking IgG Activity
Nouri-Aria, K. T., Wachholz, P. A., Francis, J. N., Jacobson, M. R., Walker, S. M., Wilcock, L. K., Staple, S. Q., Aalberse, R. C., Till, S. J., & Durham, S. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.3252 · Cited by 564
Pajno, G. B., Barberio, G., De Luca, F., Morabito, L., & Parmiani, S. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01161.x · Cited by 546
Durham, S. R., Emminger, W., Kapp, A., de Monchy, J. G. R., Rak, S., Scadding, G. K., Wurtzen, P. A., Andersen, J. S., Tholstrup, B., Riis, B., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.973 · Cited by 520
Cox, L., Larenas-Linnemann, D., Lockey, R. F., & Passalacqua, G. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.060 · Cited by 505
Novembre, E., Galli, E., Landi, F., Caffarelli, C., Pifferi, M., De Marco, E., Burastero, S. E., Calori, G., Benetti, L., Bonazza, P., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.07.012 · Cited by 499
Injection allergen immunotherapy for asthma
Abramson, M. J., Puy, R. M., & Weiner, J. M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001186.pub2 · Cited by 497
Didier, A., Malling, H.-J., Worm, M., Horak, F., Jäger, S., Montagut, A., André, C., de Beaumont, O., & Melac, M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.046 · Cited by 484
Self-citationTwelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001
Bernstein, D. I., Wanner, M., Borish, L., Liss, G. M., & the Immunotherapy Committee of th (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.02.006 · Cited by 483
Durham, S. R., Yang, W. H., Pedersen, M. R., Johansen, N., & Rak, S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1358 · Cited by 479
Pfaar, O., Demoly, P., Gerth van Wijk, R., Bonini, S., Bousquet, J., Canonica, G. W., Durham, S. R., Jacobsen, L., Malling, H. J., Mösges, R., et al. (2014) · Allergy · doi:10.1111/all.12383 · Cited by 473
Self-citationSublingual immunotherapy for allergic rhinitis
Wilson, D., Torres-Lima, M., & Durham, S. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002893 · Cited by 460
Canonica, G. W., Baena‐Cagnani, C. E., Bousquet, J., Bousquet, P. J., Lockey, R. F., Malling, H. ‐., Passalacqua, G., Potter, P., & Valovirta, E. (2007) · Allergy · doi:10.1111/j.1398-9995.2006.01312.x · Cited by 439
Burks, A. W., Calderon, M. A., Casale, T., Cox, L., Demoly, P., Jutel, M., Nelson, H., & Akdis, C. A. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.049 · Cited by 438
Dahl, R., Kapp, A., Colombo, G., de Monchy, J. G. R., Rak, S., Emminger, W., Rivas, M. F., Ribel, M., & Durham, S. R. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.05.003 · Cited by 436
Standards for practical allergen‐specific immunotherapy
Alvarez‐Cuesta, E., Bousquet, J., Canonica, G. W., Durham, S. R., Malling, H. ‐., & Valovirta, E. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01219_1.x · Cited by 402
Sublingual immunotherapy: A comprehensive review
Cox, L. S., Linnemann, D. L., Nolte, H., Weldon, D., Finegold, I., & Nelson, H. S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.040 · Cited by 396
Frew, A. J., Powell, R. J., Corrigan, C. J., & Durham, S. R. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.11.014 · Cited by 374
Senti, G., Prinz Vavricka, B. M., Erdmann, I., Diaz, M. I., Markus, R., McCormack, S. J., Simard, J. J., Wüthrich, B., Crameri, R., Graf, N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803725105 · Cited by 364
Marogna, M., Spadolini, I., Massolo, A., Canonica, G. W., & Passalacqua, G. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.030 · Cited by 360
Khinchi, M. S., Poulsen, L. K., Carat, F., André, C., Hansen, A. B., & Malling, H. ‐. (2004) · Allergy · doi:10.1046/j.1398-9995.2003.00387.x · Cited by 359
Durham, S. R., Emminger, W., Kapp, A., Colombo, G., de Monchy, J. G. R., Rak, S., Scadding, G. K., Andersen, J. S., Riis, B., & Dahl, R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.035 · Cited by 352
Di Rienzo, V., Marcucci, F., Puccinelli, P., Parmiani, S., Frati, F., Sensi, L., Canonica, G. W., & Passalacqua, G. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01587.x · Cited by 350
Sub-lingual Immunotherapy: World Allergy Organization Position Paper 2009
Bonini, S. (2009) · Allergy · Cited by 338
Bufe, A., Eberle, P., Franke-Beckmann, E., Funck, J., Kimmig, M., Klimek, L., Knecht, R., Stephan, V., Tholstrup, B., Weißhaar, C., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.044 · Cited by 336
Self-citationWahn, U., Tabar, A., Kuna, P., Halken, S., Montagut, A., de Beaumont, O., & Le Gall, M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.009 · Cited by 332
Niggemann, B., Jacobsen, L., Dreborg, S., Ferdousi, H. A., Halken, S., Høst, A., Koivikko, A., Koller, D., Norberg, L. A., Urbanek, R., et al. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01068.x · Cited by 332
Mechanisms of allergen-specific immunotherapy
Akdis, M., & Akdis, C. A. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.022 · Cited by 301
Lamb, C. E., Ratner, P. H., Johnson, C. E., Ambegaonkar, A. J., Joshi, A. V., Day, D., Sampson, N., & Eng, B. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x112552 · Cited by 288
Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile
Calderón, M. A., Simons, F. E. R., Malling, H. ‐., Lockey, R. F., Moingeon, P., & Demoly, P. (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02761.x · Cited by 286
Mosbech, H., Deckelmann, R., de Blay, F., Pastorello, E. A., Trebas-Pietras, E., Andres, L. P., Malcus, I., Ljørring, C., & Canonica, G. W. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.03.019 · Cited by 285
Werfel, T., Breuer, K., Ruéff, F., Przybilla, B., Worm, M., Grewe, M., Ruzicka, T., Brehler, R., Wolf, H., Schnitker, J., et al. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.00974.x · Cited by 283
Self-citationPurello‐D'Ambrosio, F., Gangemi, S., Merendino, R. A., Isola, S., Puccinelli, P., Parmiani, S., & Ricciardi, L. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01027.x · Cited by 281 · cited 1×
“e development of new sensitizations can be reduced in the case of mono- and oligosensitizations [138, 139, 140, 141].”
BackgroundTwelve‐year follow‐up after discontinuation of preseasonal grass pollen immunotherapy in childhood
Eng, P. A., Borer‐Reinhold, M., Heijnen, I. A. F. M., & Gnehm, H. P. E. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01011.x · Cited by 277
Self-citationIntralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
Senti, G., Crameri, R., Kuster, D., Johansen, P., Martinez-Gomez, J. M., Graf, N., Steiner, M., Hothorn, L. A., Grönlund, H., Tivig, C., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.026 · Cited by 271
Passalacqua, G., Albano, M., Fregonese, L., Riccio, A., Pronzato, C., Mela, G. S., & Canonica, G. W. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07055-4 · Cited by 260
2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis
Simons, F. E. R., Ardusso, L. R. F., Bilò, M. B., Dimov, V., Ebisawa, M., El-Gamal, Y. M., Ledford, D. K., Lockey, R. F., Ring, J., Sanchez-Borges, M., et al. (2012) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e328355b7e4 · Cited by 258
Self-citationDouble-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract
Horst, M., Hejjaoui, A., Horst, V., Michel, F.-B., & Bousquet, J. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(90)90156-x · Cited by 253
Blaiss, M., Maloney, J., Nolte, H., Gawchik, S., Yao, R., & Skoner, D. P. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.034 · Cited by 243
A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis
Carr, W., Bernstein, J., Lieberman, P., Meltzer, E., Bachert, C., Price, D., Munzel, U., & Bousquet, J. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.077 · Cited by 242
Self-citationBousquet, J., Scheinmann, P., Guinnepain, M., Perrin‐Fayolle, M., Sauvaget, J., Tonnel, A., Pauli, G., Caillaud, D., Dubost, R., Leynadier, F., et al. (1999) · Allergy · doi:10.1034/j.1398-9995.1999.00916.x · Cited by 237
Evaluation of near-fatal reactions to allergen immunotherapy injections
Amin, H. S., Liss, G. M., & Bernstein, D. I. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.010 · Cited by 231
Allergen Drives Class Switching to IgE in the Nasal Mucosa in Allergic Rhinitis
Takhar, P., Smurthwaite, L., Coker, H. A., Fear, D. J., Banfield, G. K., Carr, V. A., Durham, S. R., & Gould, H. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.5024 · Cited by 230
GA2LEN/EAACI pocket guide for allergen‐specific immunotherapy for allergic rhinitis and asthma
Zuberbier, T., Bachert, C., Bousquet, P. J., Passalacqua, G., Walter Canonica, G., Merk, H., Worm, M., Wahn, U., & Bousquet, J. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02474.x · Cited by 227
Self-citationRing, J., Beyer, K., Biedermann, T., Bircher, A., Duda, D., Fischer, J., Friedrichs, F., Fuchs, T., Gieler, U., Jakob, T., et al. (2014) · Allergo Journal International · doi:10.1007/s40629-014-0009-1 · Cited by 222
Self-citationPajno, G. B., Morabito, L., Barberio, G., & Parmiani, S. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00495.x · Cited by 216
Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults
Nelson, H. S., Nolte, H., Creticos, P., Maloney, J., Wu, J., & Bernstein, D. I. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.035 · Cited by 216
Bergmann, K.-C., Demoly, P., Worm, M., Fokkens, W. J., Carrillo, T., Tabar, A. I., Nguyen, H., Montagut, A., & Zeldin, R. K. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.11.012 · Cited by 208
Self-citationSublingual immunotherapy for allergic rhinitis
Radulovic, S., Calderon, M. A., Wilson, D., & Durham, S. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002893.pub2 · Cited by 206
Long-term efficacy of preseasonal grass pollen immunotherapy in children
Eng, P. A., Reinhold, M., & Gnehm, H. E. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.1o3264.x · Cited by 203
Self-citationDahl, R., Stender, A., & Rak, S. (2006) · Allergy · doi:10.1111/j.1398-9995.2005.00949.x · Cited by 203
Bae, J. M., Choi, Y. Y., Park, C. O., Chung, K. Y., & Lee, K. H. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.02.044 · Cited by 201
Patel, D., Couroux, P., Hickey, P., Salapatek, A. M., Laidler, P., Larché, M., & Hafner, R. P. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.028 · Cited by 198
Allergen immunotherapy: a practice parameter
Li, J. T., Lockey, R. F., Bernstein, I. L., Portnoy, J. M., & Nicklas, R. A. (2003) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63600-9 · Cited by 197
Van Ree, R., Chapman, M. D., Ferreira, F., Vieths, S., Bryan, D., Cromwell, O., Villalba, M., Durham, S. R., Becker, W. M., Aalbers, M., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01612.x · Cited by 196
Yukselen, A., Kendirli, S. G., Yilmaz, M., Altintas, D. U., & Karakoc, G. B. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000327566 · Cited by 189
Calderón, M. A., Casale, T. B., Togias, A., Bousquet, J., Durham, S. R., & Demoly, P. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.024 · Cited by 187
Karlsson, R., Agrell, B., Dreborg, S. K. G., Foucard, T., Kjellman, N. ‐. M., Koivikko, A., & EINARSSON, R. (1986) · Allergy · doi:10.1111/j.1398-9995.1986.tb00290.x · Cited by 186
Corrigan, C. J., the Study Group, Kettner, J., Doemer, C., Cromwell, O., & Narkus, A. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00790.x · Cited by 184
Immunotherapy for allergic rhinitis
Walker, S. M., Durham, S. R., Till, S. J., Roberts, G. C., Corrigan, C. J., Leech, S. C., Krishna, M. T., Rajakulasingham, R. K., Williams, A., Chantrell, J., et al. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03794.x · Cited by 183
Dretzke, J., Meadows, A., Novielli, N., Huissoon, A., Fry-Smith, A., & Meads, C. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.02.013 · Cited by 182
Marogna, M., Spadolini, I., Massolo, A., Canonica, G. W., & Passalacqua, G. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00508.x · Cited by 182
Hirsch, T., Sähn, M., & Leupold, W. (1997) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.1997.tb00138.x · Cited by 182
Sub-lingual Immunotherapy: World Allergy Organization Position Paper 2009
Canonica, G., Bousquet, J., Casale, T., Lockey, R., Ce, B.-C., Pawankar, R., Potter, P., Bousquet, P., Cox, L., Durham, Sr., et al. (2009) · UCL Discovery (University College London) · Cited by 180
Self-citationBahçeciler, N. N., Işik, U., Barlan, I. B., & Başaran, M. M. (2001) · Pediatric Pulmonology · doi:10.1002/ppul.1088 · Cited by 169
Reisinger, J., Horak, F., Pauli, G., van Hage, M., Cromwell, O., König, F., Valenta, R., & Niederberger, V. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.04.003 · Cited by 166
House dust mite control measures for asthma: systematic review
Gøtzsche, P. C., & Johansen, H. K. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01690.x · Cited by 166
Why do doctors and patients not follow guidelines?
Baiardini, I., Braido, F., Bonini, M., Compalati, E., & Canonica, G. W. (2009) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/aci.0b013e32832b4651 · Cited by 165
Zielen, S., Kardos, P., & Madonini, E. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.002 · Cited by 162
Passalacqua, G., Baena-Cagnani, C. E., Bousquet, J., Canonica, G. W., Casale, T. B., Cox, L., Durham, S. R., Larenas-Linnemann, D., Ledford, D., Pawankar, R., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.039 · Cited by 161
Immunotherapy with partially purified and standardized animal dander extracts
Sundin, B., Lilja, G., Graff‐Lonnevig, V., Hedlin, G., Heilborn, H., Norrlind, K., Pegelow, K.-O., & Lewenstein, H. (1986) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(86)90183-1 · Cited by 161
Immunotherapy with cat- and dog-dander extracts
Hedlin, G., Graff-Lonnevig, V., Heilborn, H., Lilja, G., Norrlind, K., Pegelow, K., Sundin, B., & Lowenstein, H. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90417-m · Cited by 159
Senti, G., von Moos, S., Tay, F., Graf, N., Sonderegger, T., Johansen, P., & Kündig, T. M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.08.036 · Cited by 158
Dreborg, S. K. G., Agrell, B., Foucard, T., Kjellman, N. ‐. M., Koivikko, A., & Nillson, S. (1986) · Allergy · doi:10.1111/j.1398-9995.1986.tb00289.x · Cited by 156
Guez, S., Vatrinet, C., Fadel, R., & André, C. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00413.x · Cited by 155
Immunotherapy with cat- and dog-dander extracts
Lilja, G., Sundin, B., Graff‐Lonnevig, V., Hedlin, G., Heilborn, H., Norrlind, K., Pegelow, K., & Løwenstein, H. (1989) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(89)90475-2 · Cited by 154
Ott, H., Sieber, J., Brehler, R., Fölster‐Holst, R., Kapp, A., Klimek, L., Pfaar, O., & Merk, H. F. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01875.x · Cited by 149
Self-citationSpecific immunotherapy in asthma
Bousquet, J., Hejjaoui, A., & Michel, F. B. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80091-0 · Cited by 145
Nanda, A., O'Connor, M., Anand, M. K., Dreskin, S. C., Zhang, L., Hines, B. T., Lane, D., Wheat, W. H., Routes, J. M., Sawyer, R. T., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.049 · Cited by 143
Bußmann, C., Böckenhoff, A., Henke, H., Werfel, T., & Novak, N. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.07.054 · Cited by 141
Guidelines for Diagnosis and Treatment of Asthma Patients
Buhl, R., Berdel, D., Criée, C.-P., Gillissen, A., Kardos, P., Kroegel, C., Leupold, W., Lindemann, H., Magnussen, H., Nowak, D., et al. (2006) · Pneumologie · doi:10.1055/s-2005-919153 · Cited by 138
Self-citationDiagnosis and Immunotherapy of Mould Allergy
Malling, H. ‐., Dreborg, S. K. G., & Weeke, B. (1986) · Allergy · doi:10.1111/j.1398-9995.1986.tb00336.x · Cited by 136
Calderón, M. A., Casale, T. B., Nelson, H. S., & Demoly, P. M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.004 · Cited by 134
Allam, J., Würtzen, P. A., Reinartz, M., Winter, J., Vrtala, S., Chen, K., Valenta, R., Wenghoefer, M., Appel, T., Gros, E., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.04.039 · Cited by 134
Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet
de Groot, H., & Bijl, A. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.01998.x · Cited by 132
The oral allergy syndrome: improved diagnostic and treatment methods
Mari, A., Ballmer-Weber, B. K., & Vieths, S. (2005) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000168793.27948.b0 · Cited by 131
Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma
Roberts, G. C., Hurley, C., Turcanu, V., & Lack, G. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.054 · Cited by 131
Nielsen, L., Johnsen, C. R., Mosbech, H., Poulsen, L. K., & Malling, H. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)70186-0 · Cited by 125
Frost, L., Johansen, P., Pedersen, S., Veien, N. K., AabelØstergaard, P., & Nielsen, M. H. (1985) · Allergy · doi:10.1111/j.1398-9995.1985.tb00249.x · Cited by 124
Use of β-blockers during immunotherapy for Hymenoptera venom allergy
Müller, U., & Haeberli, G. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.012 · Cited by 120
Lue, K., Lin, Y., Sun, H., et al. (2006) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2006.00443.x · Cited by 119
Intralymphatic Injections as a New Administration Route for Allergen-Specific Immunotherapy
Martínez-Gómez, J. M., Johansen, P., Erdmann, I., Senti, G., Crameri, R., & Kündig, T. M. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000210381 · Cited by 117
DuBuske, L. M., Frew, A. J., Horak, F., Keith, P. K., Corrigan, C. J., Aberer, W., Holdich, T., & von Weikersthal-Drachenberg, K. J. F. (2011) · Allergy and Asthma Proceedings · doi:10.2500/aap.2011.32.3453 · Cited by 116
A 1‐year, placebo‐controlled, double‐blind house‐dust‐mite immunotherapy study in asthmatic adults
Olsen, O. T., Larsen, K. R., Jacobsen, L., & Svendsen, U. G. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb02157.x · Cited by 115
Niu, C.-K., Chen, W.-Y., Huang, J., Lue, K., & Wang, J. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2005.11.016 · Cited by 114
Devillier, P., Dreyfus, J., Demoly, P. M., & Calderón, M. A. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-71 · Cited by 114
Long-term follow-up of patients treated with a three-year course of cat or dog immunotherapy
Hedlin, G., Heilborn, H., Lilja, G., et al. (1995) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(95)70223-7 · Cited by 113
Novak, N., Bieber, T. R. M., Hoffmann, M., Fölster‐Holst, R., Homey, B., Werfel, T., Sager, A., & Zuberbier, T. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.08.004 · Cited by 113
Reimers, A., Hari, Y., & Müller, U. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00520.x · Cited by 112
How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint
Senna, G., Lombardi, C., Canonica, G. W., & Passalacqua, G. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.045 · Cited by 112
Pichler, C. E., Marquardsen, A., Sparholt, S. H., Løwenstein, H., Bircher, A. J., Bischof, M., & Pichler, W. J. (1997) · Allergy · doi:10.1111/j.1398-9995.1997.tb00991.x · Cited by 109
García-Robaina, J. C., Sánchez, I., de la Torre, F., Fernández‐Caldas, E., & Casanovas, M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.07.043 · Cited by 109
Vogelbruch, M., Nuß, B., Körner, M., Kapp, A., Kiehl, P., & Bohm, W. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00501.x · Cited by 108
Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children
Kuna, P., Kaczmarek, J., & Kupczyk, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.036 · Cited by 106
Bødtger, U. C. S., Poulsen, L. K., Jacobi, H., & Malling, H. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.1o3532.x · Cited by 106
Varney, V., Tabbah, K., Mavroleon, G., & Frew, A. J. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01735.x · Cited by 106
Matricardi, P. M., Kuna, P., Panetta, V., Wahn, U., & Narkus, A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.049 · Cited by 105
Prophylactic Inoculation against Hay Fever
Noon, L. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000228032 · Cited by 98
Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses
Compalati, E., Penagos, M., Tarantini, F., Passalacqua, G., & Canonica, G. W. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60103-2 · Cited by 97
Didier, A. P., Malling, H. ‐., Worm, M., Horak, F., Sussman, G. L., Mélac, M., Soulié, S., & Zeldin, R. K. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12100 · Cited by 97
Self-citationWang, H., Lin, X., Hao, C., Zhang, C., Sun, B., Zheng, J., Chen, P.-L., Sheng, J., Wu, A. Q., & Zhong, N. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00913.x · Cited by 95
Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study.
Horak, F., Stübner, P., Berger, U. E., Marks, B., Toth, J., & Jäger, S. (1998) · PubMed · Cited by 92
Evidence of adherence to allergen-specific immunotherapy
Senna, G., Ridolo, E., Calderón, M. A., Lombardi, C., Canonica, G. W., & Passalacqua, G. (2009) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328332b8df · Cited by 92
Tonnel, A., Scherpereel, A., Douay, B., Mellin, B., Leprince, D., Goldstein, N., Delecluse, P., & André, C. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00456.x · Cited by 91
Birch-Apple Syndrome Treated with Birch Pollen Immunotherapy
Mauro, M., Russello, M., Incorvaia, C., Gazzola, G., Frati, F., Moingeon, P., & Passalacqua, G. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000323909 · Cited by 90 · cited 1×
“A randomized controlled trial (on 40 tree pollen allergic patients, 20 of whom were treated with SCIT and 20 treated with SLIT) demonstrated an improvement of the OAS in some of the patients [94].”
BackgroundArvidsson, M., Lowhagen, O., & Rak, S. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.123868 · Cited by 90
Epstein, T. G., Liss, G. M., Murphy-Berendts, K. J., & Bernstein, D. I. (2013) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2013.01.015 · Cited by 89
Passalacqua, G., Pasquali, M., Ariano, R., Lombardi, C., Giardini, A., Baiardini, I., Majani, G., Falagiani, P., Bruno, M., & Canonica, G. W. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01095.x · Cited by 88
Ameal, A., Vega‐Chicote, J. M., Fernández, S., Miranda, A., Carmona, M. J., Rondon, M. C., Reina, E., & García‐González, J. J. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00862.x · Cited by 87
Blumberga, G., Groes, L., Haugaard, L., & Dahl, R. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01088.x · Cited by 85
Valovirta, E. J., Berstad, A. K. H., Jacques de, B. L. I. C., Bufe, A., Eng, P. A., Halken, S., Ojeda, P., Roberts, G. C., Tommerup, L., Varga, E., et al. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.09.013 · Cited by 81
Self-citationvan Neerven, R. J. J., Arvidsson, M., Ipsen, H., Sparholt, S. H., Rak, S., & Würtzen, P. A. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01899.x · Cited by 81
Schädlich, P. K., & Brecht, J. G. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017010-00003 · Cited by 80
Wahn, U., Klimek, L., Płoszczuk, A., Adelt, T., Sandner, B., Trębas-Pietraś, E., Eberle, P., & Bufe, A. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.047 · Cited by 79
Self-citationLinneberg, A. R., Jacobsen, R. K., Jespersen, L., & Abildstrom, S. Z. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.09.007 · Cited by 78
Bousquet, J., Schünemann, H. J., Bousquet, P. J., Bachert, C., Canonica, G. W., Casale, T. B., Demoly, P. M., Durham, S. R., Carlsen, K. H., Malling, H. ‐., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02590.x · Cited by 76
Self-citationPfaar, O., Urry, Z., Robinson, D. S., SAGER, A. R., Richards, D. F., Hawrylowicz, C. M., Bräutigam, M., & Klimek, L. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02736.x · Cited by 72
Self-citationKelso, J. M. (2004) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61551-7 · Cited by 71
Sieber, J., Geest, S. D., Shah‐Hosseini, K., & Mösges, R. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.559538 · Cited by 71
Clark, J., & Schall, R. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01469.x · Cited by 70
Minimising the Risks of Allergen-Specific Injection Immunotherapy
Malling, H.-J. (2000) · Drug Safety · doi:10.2165/00002018-200023040-00005 · Cited by 69
Neubewertung des Risikos von Test- und Therapieallergenen
Lüderitz-Püchel, U., Keller‐Stanislawski, B., & Haustein, D. (2001) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s001030100201 · Cited by 67
Brüggenjürgen, B., Reinhold, T., Brehler, R., Laake, E., Wiese, G., Machate, U., & Willich, S. N. (2008) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60498-x · Cited by 67
Pfaar, O., & Klimek, L. (2008) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60451-6 · Cited by 65
Self-citationPfaar, O., Cazan, D., Klimek, L., Larenas‐Linnemann, D. E., & Calderón, M. A. (2012) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32835a11d6 · Cited by 61
Self-citationPatient’s compliance with allergen immunotherapy
Incorvaia, C. (2008) · Patient Preference and Adherence · doi:10.2147/ppa.s3806 · Cited by 61
Worm, M., Rak, S., Frederic de, B. L. A. Y., Malling, H. ‐., Mélac, M., Cadic, V., & Zeldin, R. K. (2014) · Clinical and Translational Allergy · doi:10.1186/2045-7022-4-7 · Cited by 61
Self-citationAluminium allergy in patients hyposensitized with aluminium‐precipitated antigen extracts
Lopez, S., Peláez, A., Navarro, L. A., Montesinos, E., Morales, C., & Cardá, C. (1994) · Contact Dermatitis · doi:10.1111/j.1600-0536.1994.tb01903.x · Cited by 60
Grouin, J., Vicaut, É., Jean-Alphonse, S., Demoly, P. M., Wahn, U., Didier, A. P., de Beaumont, O., Montagut, A., Gall, M. L., & Devillier, P. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03700.x · Cited by 59
Netterlid, E., Hindsén, M., Björk, J., Ekqvist, S., Güner, N., Henricson, K. Å., & Bruze, M. (2009) · Contact Dermatitis · doi:10.1111/j.1600-0536.2008.01474.x · Cited by 59
Efficacy and Safety of a Glutaraldehyde-Modified House Dust Mite Extract in Allergic Rhinitis
Riechelmann, H., Schmutzhard, J., van der Werf, J. F., Distler, A., & Kleinjans, H. A. J. (2010) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2010.24.3508 · Cited by 59
Agreement of efficacy assessments for five‐grass pollen sublingual tablet immunotherapy
Didier, A. P., Mélac, M., Montagut, A., Lhéritier‐Barrand, M., Tabar, A. I., & Worm, M. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01767.x · Cited by 57
Self-citationPajno, G. B., Caminiti, L., Crisafulli, G., Vita, D., Valenzise, M., Luca, R. D., & Passalacqua, G. (2011) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2011.01196.x · Cited by 56
Schmid‐Grendelmeier, P. (2010) · Der Hautarzt · doi:10.1007/s00105-010-1967-y · Cited by 55
Self-citationPharmacokinetics of Der p 2 Allergen and Derived Monomeric Allergoid in Allergic Volunteers
Bagnasco, M., Altrinetti, V., Pesce, G., Caputo, M., Mistrello, G., Falagiani, P., Canonica, G. W., & Passalacqua, G. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000088719 · Cited by 55
Nonfatal systemic reactions to subcutaneous immunotherapy: a 10-year experience.
Ragusa, F. V., Passalacqua, G., Gambardella, R., Campanari, S., Barbieri, M., Scordamaglia, A., & Canonica, G. W. (1997) · PubMed · Cited by 55
Allergen-Specific Immunotherapy: Which Outcome Measures are Useful in Monitoring Clinical Trials?
Pfaar, O., Kleine‐Tebbe, J., Hörmann, K., & Klimek, L. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.02.004 · Cited by 52
Self-citationTreatment of Allergic Rhinitis During Pregnancy
Demoly, P. M., Piette, V., & Daurès, J. (2003) · Drugs · doi:10.2165/00003495-200363170-00004 · Cited by 52
Allergen specific immunotherapy for atopic dermatitis
Novak, N. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282f1d66c · Cited by 52
Cox, L., Calderón, M. A., & Pfaar, O. (2012) · Immunotherapy · doi:10.2217/imt.12.36 · Cited by 52
Self-citationPfaar, O., Robinson, D. S., SAGER, A. R., & Emuzyte, R. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02413.x · Cited by 51
Self-citationRole of immunmodulators in allergen-specific immunotherapy: SIT and immunmodulators
Kopp, M. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02553.x · Cited by 51
Self-citationTowards evidence‐based medicine in specific grass pollen immunotherapy
Calderón, M. A., Mösges, R., Hellmich, M., & Demoly, P. M. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02292.x · Cited by 50
Balda, B.-R., Wolf, H., Baumgarten, C., Klimek, L., Rasp, G., Kunkel, G., Müller, S., Mann, W. J., Hauswald, B., Heppt, W. J., et al. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb03969.x · Cited by 50
Self-citationBrehler, R., Klimek, L., Kopp, M., & Virchow, J. C., Jr. (2013) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2013.0148 · Cited by 49
Self-citationRekombinante Allergene. Routinediagnostik oder Wissenschaft?
Schmid‐Grendelmeier, P. (2010) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-43895 · Cited by 49
Self-citationThe CONSORT statement checklist in allergen‐specific immunotherapy: a GA2LEN paper
Bousquet, P., Brozek, J., Bachert, C., Bieber, T. R. M., Bonini, S., Burney, P., Calderón, M. A., Canonica, G. W., Compalati, E., Daurès, J., et al. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02232.x · Cited by 47
Self-citationPfaar, O., Biedermann, T., Klimek, L., SAGER, A. R., & Robinson, D. S. (2013) · Allergy · doi:10.1111/all.12219 · Cited by 47
Self-citationHöiby, A. ‐., Strand, V., Robinson, D. S., Sager, A., & Rak, S. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03521.x · Cited by 44
Westerhout, K. Y., Verheggen, B. G., Schreder, C. H., & Augustin, M. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.688904 · Cited by 44
Use of omalizumab to improve desensitization safety in allergen immunotherapy
Larenas‐Linnemann, D. E., Wahn, U., & Kopp, M. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1089 · Cited by 39
Self-citationNew routes for allergen immunotherapy
Johansen, P., Moos, S. C. V., Mohanan, D., Kündig, T. M., & Senti, G. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.21948 · Cited by 39
Jutel, M., Solarewicz-Madejek, K., & Smolińska, S. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.22064 · Cited by 37
Accelerated Immunotherapy Schedules
Calabria, C. W. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0356-x · Cited by 35
Calderón, M. A., Eichel, A., Makatsori, M., & Pfaar, O. (2012) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32835358b3 · Cited by 33
Self-citationAllergen-specific immunotherapy and risk of autoimmune disease
Linneberg, A. R., Madsen, F., & Skaaby, T. (2012) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3283588c8d · Cited by 28
Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax®) in children
Taylor, M. J., Ronaldson, S. J., Shenton, R. C., Bech, P. G., & Bufe, A. (2014) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s44079 · Cited by 28
Self-citationSublingual Immunotherapy for Allergic Rhinitis and Conjunctivitis
Passalacqua, G., Garelli, V., Sclifò, F., & Canonica, G. W. (2013) · Immunotherapy · doi:10.2217/imt.12.157 · Cited by 27
Specific immunotherapy with allergen mixes: what is the evidence?
Nelson, H. S. (2009) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328330ee69 · Cited by 25
Malignancy and Specific Allergen Immunotherapy: The Results of a Case Series
Wöhrl, S., Kinaciyan, T., Jalili, A., Stingl, G., & Moritz, K. B. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000323519 · Cited by 24
Self-citationDrachenberg, K. J., Heinzkill, M., & Urban, E. (2002) · Allergologie · doi:10.5414/alp25466 · Cited by 23
Randhawa, I., Junaid, I., & Klaustermeyer, W. B. (2007) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60767-3 · Cited by 22
Makatsori, M., & Calderón, M. A. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000075 · Cited by 21
Kopp, M., Niggemann, B., & Forster, J. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02195.x · Cited by 17
Self-citationPharmakoprophylaxe und Begleitmedikation bei spezifischer Immuntherapie
Wedi, B., & Ruëff, F. (2011) · Der Hautarzt · doi:10.1007/s00105-011-2157-2 · Cited by 15
Self-citationClaes, C., Mittendorf, T., & von der Schulenburg, J. M. G. (2009) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-009-1113-8 · Cited by 15
The acute and long‐term management of anaphylaxis: protocol for a systematic review
Dhami, S., Panesar, S. S., Rader, T., Muraro, A. M., Roberts, G. C., Worm, M., Sheikh, A., & EAACI Food Allergy and Anaphylaxis Guidelines group (2013) · Clinical and Translational Allergy · doi:10.1186/2045-7022-3-14 · Cited by 15
Self-citationAccelerated Immunotherapy Schedules and Premedication
Calabria, C. W., & Cox, L. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.02.001 · Cited by 14
Specific Immunotherapy (hyposensitization) for IgE-mediated allergic diseases*
Kleine‐Tebbe, J., Bufe, A., Ebner, C., Eigenmann, P., Friedrichs, F., Fuchs, T., Huttegger, I., Jung, J. Y., Klimek, L., Kopp, M., et al. (2010) · GRO · Cited by 10
Self-citationPraktische Durchführung der Hyposensibilisierung
Fischer, P. J., & Friedrichs, F. (2013) · Monatsschrift Kinderheilkunde · doi:10.1007/s00112-012-2803-5 · Cited by 6
Self-citation
Cited by
Bousquet, J., Anto, J. M., Bachert, C., Baiardini, I., Bosnic-Anticevich, S., Walter Canonica, G., Melén, E., Palomares, O., Scadding, G. K., Togias, A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00227-0 · Cited by 942
Self-citationEAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis
Roberts, G., Pfaar, O., Akdis, C. A., Ansotegui, I. J., Durham, S. R., Gerth van Wijk, R., Halken, S., Larenas‐Linnemann, D., Pawankar, R., Pitsios, C., et al. (2018) · Allergy · doi:10.1111/all.13317 · Cited by 702
Self-citationInternational Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
Self-citationInternational consensus on allergy immunotherapy
Jutel, M., Agache, I., Bonini, S., Burks, A. W., Calderon, M., Canonica, W., Cox, L., Demoly, P., Frew, A. J., O'Hehir, R., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.047 · Cited by 545
Self-citationInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Metadata
- Authors
- Pfaar, O., Bachert, C., Bufe, A., Buhl, R., Ebner, C., Eng, P., Friedrichs, F., Fuchs, T., Hamelmann, E., Hartwig-Bade, D., Hering, T., Huttegger, I., Jung, K., Klimek, L., Kopp, M. V., Merk, H., Rabe, U., Saloga, J., Schmid-Grendelmeier, P., Schuster, A., Schwerk, N., Sitter, H., Umpfenbach, U., Wedi, B., Wöhrl, S., Worm, M., & Kleine-Tebbe, J.
- Venue
- Allergo Journal International
- Published
- 2014-12
- Volume
- 23
- Issue
- 8
- Pages
- 282-319
- ISSN
- 2197-0378 (ISSN-L)
- OpenAlex
- W43591453
- Cited by
- 351
- References
- 195
- FWCI
- 25.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.